Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cianchetti

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Minerva Chirurgica|September 15, 1990
[Carcinoma of the male breast. Our experience]E Cianchetti, R Cotellese, A Dell'Osa, et al.
Anticancer Research|May 16, 2000
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancerC Natoli, M T Scognamiglio, M T Martino, et al.
Panminerva Medica|January 1, 1989
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary reportG Belcaro, M Legnini, E Cianchetti, et al.
Panminerva Medica|October 1, 1988
Laser-Doppler flowmetry evaluation of the effects of elastic compression in patients with venous ulcerationsG Belcaro, G Laurora, M R Cesarone, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Atherosclerosis: a classic inflammatory diseaseA Anogeianaki, D Angelucci, E Cianchetti, et al.
Human Mutation|July 23, 2003
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central ItalyL Stuppia, P Di Fulvio, G Aceto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancerC Natoli, E Cianchetti, N Tinari, et al.
International Journal of Immunopathology and Pharmacology|April 18, 2012
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammationS Tete, D Tripodi, M Rosati, et al.
Journal of Biological Regulators and Homeostatic Agents|January 6, 2012
Cholesterol and vitamins: revisited studyA Saggini, A Anogeianaki, D Angelucci, et al.
International Journal of Immunopathology and Pharmacology|March 27, 2013
IL-36 receptor antagonist with special emphasis on IL-38Y Shaik, G Sabatino, G Maccauro, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Minerva Chirurgica|September 15, 1990
[Carcinoma of the male breast. Our experience]E Cianchetti, R Cotellese, A Dell'Osa, et al.
Anticancer Research|May 16, 2000
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancerC Natoli, M T Scognamiglio, M T Martino, et al.
Panminerva Medica|January 1, 1989
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary reportG Belcaro, M Legnini, E Cianchetti, et al.
Panminerva Medica|October 1, 1988
Laser-Doppler flowmetry evaluation of the effects of elastic compression in patients with venous ulcerationsG Belcaro, G Laurora, M R Cesarone, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Atherosclerosis: a classic inflammatory diseaseA Anogeianaki, D Angelucci, E Cianchetti, et al.
Human Mutation|July 23, 2003
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central ItalyL Stuppia, P Di Fulvio, G Aceto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancerC Natoli, E Cianchetti, N Tinari, et al.
International Journal of Immunopathology and Pharmacology|April 18, 2012
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammationS Tete, D Tripodi, M Rosati, et al.
Journal of Biological Regulators and Homeostatic Agents|January 6, 2012
Cholesterol and vitamins: revisited studyA Saggini, A Anogeianaki, D Angelucci, et al.
International Journal of Immunopathology and Pharmacology|March 27, 2013
IL-36 receptor antagonist with special emphasis on IL-38Y Shaik, G Sabatino, G Maccauro, et al.
Pageof 5